Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Gemphire Therapeutics Inc (GEMP)

Gemphire Therapeutics Inc (GEMP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.30 unch (unch) 12/30/19 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.30 unch (unch) -
Quote Overview for Mon, Dec 30th, 2019
Day Low
0.29
Day High
0.34
Open 0.31
Previous Close 0.30 0.30
Volume 191,000 191,000
Avg Vol 125,430 125,430
Stochastic %K 54.09% 54.09%
Weighted Alpha -67.70 -67.70
5-Day Change unch (unch) unch (unch)
52-Week Range 0.24 - 1.49 0.24 - 1.49
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,462
  • Shares Outstanding, K 14,872
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,640 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.73
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/02/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.24 +26.05%
on 12/06/19
Period Open: 0.36
0.39 -22.46%
on 12/03/19
-0.06 (-16.43%)
since 11/29/19
3-Month
0.24 +26.05%
on 12/06/19
Period Open: 0.38
0.44 -31.82%
on 10/22/19
-0.08 (-21.42%)
since 09/30/19
52-Week
0.24 +26.05%
on 12/06/19
Period Open: 0.77
1.49 -79.80%
on 03/06/19
-0.47 (-61.04%)
since 12/28/18

Business Summary

Gemphire Therapeutics Inc. is a biopharmaceutical company. It focused on developing and commercializing therapies for the treatment of dyslipidemia. The company's product candidate is gemcabene (CI-1027), an oral therapy for patients who are unable to achieve normal levels of LDL-C or triglycerides with...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.36
1st Resistance Point 0.33
Last Price 0.30
1st Support Level 0.28
2nd Support Level 0.26
3rd Support Level N/A

See More

52-Week High 1.49
Fibonacci 61.8% 1.01
Fibonacci 50% 0.86
Fibonacci 38.2% 0.71
Last Price 0.30
52-Week Low 0.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies